242 related articles for article (PubMed ID: 11802213)
41. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
[TBL] [Abstract][Full Text] [Related]
42. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G
Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807
[TBL] [Abstract][Full Text] [Related]
43. Induction of MHC class I expression by the MHC class II transactivator CIITA.
Martin BK; Chin KC; Olsen JC; Skinner CA; Dey A; Ozato K; Ting JP
Immunity; 1997 May; 6(5):591-600. PubMed ID: 9175837
[TBL] [Abstract][Full Text] [Related]
44. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
Dong Y; Rohn WM; Benveniste EN
J Immunol; 1999 Apr; 162(8):4731-9. PubMed ID: 10202014
[TBL] [Abstract][Full Text] [Related]
45. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
Geirsson A; Paliwal I; Lynch RJ; Bothwell AL; Hammond GL
Transplantation; 2003 Jul; 76(2):387-94. PubMed ID: 12883198
[TBL] [Abstract][Full Text] [Related]
46. Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon-gamma (IFN-gamma).
Kadota Y; Okumura M; Miyoshi S; Kitagawa-Sakakida S; Inoue M; Shiono H; Maeda Y; Kinoshita T; Shirakura R; Matsuda H
Clin Exp Immunol; 2000 Jul; 121(1):59-68. PubMed ID: 10886240
[TBL] [Abstract][Full Text] [Related]
47. Escape of human cytomegalovirus from HLA-DR-restricted CD4(+) T-cell response is mediated by repression of gamma interferon-induced class II transactivator expression.
Le Roy E; Mühlethaler-Mottet A; Davrinche C; Mach B; Davignon JL
J Virol; 1999 Aug; 73(8):6582-9. PubMed ID: 10400755
[TBL] [Abstract][Full Text] [Related]
48. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells.
Rigaud G; De Lerma Barbaro A; Nicolis M; Cestari T; Ramarli D; Riviera AP; Accolla RS
J Immunol; 1996 Jun; 156(11):4254-8. PubMed ID: 8666795
[TBL] [Abstract][Full Text] [Related]
49. Class II transactivator (CIITA) isoform expression and activity in melanoma.
Baton F; Deruyffelaere C; Chapin M; Prod'homme T; Charron D; Al-Daccak R; Alcaide-Loridan C
Melanoma Res; 2004 Dec; 14(6):453-61. PubMed ID: 15577315
[TBL] [Abstract][Full Text] [Related]
50. Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells.
Chou SD; Khan AN; Magner WJ; Tomasi TB
Int Immunol; 2005 Nov; 17(11):1483-94. PubMed ID: 16210330
[TBL] [Abstract][Full Text] [Related]
51. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
[TBL] [Abstract][Full Text] [Related]
52. Correlation of class II transactivator with HLA-DR antigen and its implications.
Xu KL; Li H; Pan XY; Li ZY; Lu QX; Zhang Y; Zhu HH; DU B; Zeng LY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):147-51. PubMed ID: 17490542
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors.
Sadeghi MM; Tiglio A; Sadigh K; O'Donnell L; Collinge M; Pardi R; Bender JR
Transplantation; 2001 May; 71(9):1262-8. PubMed ID: 11397960
[TBL] [Abstract][Full Text] [Related]
54. The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells.
Kwak B; Mulhaupt F; Veillard N; Pelli G; Mach F
Swiss Med Wkly; 2001 Jan; 131(3-4):41-6. PubMed ID: 11219190
[TBL] [Abstract][Full Text] [Related]
55. [Major histocompatibility complex class II transactivator (CIITA) hammer- head ribozyme transfer inhibits major histocompatibility complex class II (MHC-II) expression in Jukart cells].
Guo R; Zou P; Song YP; Ma J; Lu HZ; Cao YL; Tong YJ
Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):925-8. PubMed ID: 14723817
[TBL] [Abstract][Full Text] [Related]
56. Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-gamma inducibility in non-small cell lung carcinoma cells. Lack of surface class II expression associated with a specific defect in HLA-DRA induction.
Lu Y; Boss JM; Hu SX; Xu HJ; Blanck G
J Immunol; 1996 Apr; 156(7):2495-502. PubMed ID: 8786310
[TBL] [Abstract][Full Text] [Related]
57. Repression of IFN-gamma induction of class II transactivator: a role for PRDM1/Blimp-1 in regulation of cytokine signaling.
Tooze RM; Stephenson S; Doody GM
J Immunol; 2006 Oct; 177(7):4584-93. PubMed ID: 16982896
[TBL] [Abstract][Full Text] [Related]
58. Thyrotropin-mediated repression of class II trans-activator expression in thyroid cells: involvement of STAT3 and suppressor of cytokine signaling.
Kim H; Suh JM; Hwang ES; Kim DW; Chung HK; Song JH; Hwang JH; Park KC; Ro HK; Jo EK; Chang JS; Lee TH; Lee MS; Kohn LD; Shong M
J Immunol; 2003 Jul; 171(2):616-27. PubMed ID: 12847226
[TBL] [Abstract][Full Text] [Related]
59. The arginine methyltransferase PRMT5 regulates CIITA-dependent MHC II transcription.
Fan Z; Kong X; Xia J; Wu X; Li H; Xu H; Fang M; Xu Y
Biochim Biophys Acta; 2016 May; 1859(5):687-96. PubMed ID: 26972221
[TBL] [Abstract][Full Text] [Related]
60. Epigenetic modification and preliminary investigation of the mechanism of the immune evasion of HL-60 cells.
Liu JH; Bian YM; Xie Y; Lu DP
Mol Med Rep; 2015 Jul; 12(1):1059-65. PubMed ID: 25815463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]